You are here: All Products  > Shenzhen Hepalink Pharma Enters $441 Million Deal for Resverlogix CV Drug

Shenzhen Hepalink Pharma Enters $441 Million Deal for Resverlogix CV Drug

Price: $5.00
Available
Get instant access to this article for unlimited viewing and/or downloading for seven days.

Back to products